Showing results (461-470 of 658) with videos related to

Sort By:
Pageof 66
Biorxiv : the Preprint Server for Biology|February 19, 2024
T-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over timeShashidhar Ravishankar, Andrea M H Towlerton, Iyabode L Tiamiyu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine TrialKwabena Asare, Tsion Andine, Nivashnee Naicker, et al.
Lancet (London, England)|February 28, 2004
Dual HIV-1 infection associated with rapid disease progressionGeoffrey S Gottlieb, David C Nickle, Mark A Jensen, et al.
NPJ Vaccines|September 20, 2022
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccineCorey Casper, Lawrence Corey, Jeffrey I Cohen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.
JCI Insight|February 8, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.
The Journal of Experimental Medicine|August 27, 2003
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognitionWhitney A Macdonald, Anthony W Purcell, Nicole A Mifsud, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|March 18, 2022
Development of flow cytometry-based assays to assess the ability of antibodies to bind to SARS-CoV-2-infected and spike-transfected cells and mediate NK cell degranulationDieter Mielke, Sherry Stanfield-Oakley, Shalini Jha, et al.
The Lancet. Infectious Diseases|February 25, 2014
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili studyGlenda E Gray, Zoe Moodie, Barbara Metch, et al.
Pageof 66